SRF revises capex for specialty fluoropolymers facility
The revised capex is Rs. 745 crore and the facility is expected to be operational by December 2026
The revised capex is Rs. 745 crore and the facility is expected to be operational by December 2026
GFL’s long-term vision is to establish itself as a globally trusted and technologically advanced partner for the semiconductor industry
In the future, a commercially available fluorine elastomer sealing ring could consist of a fluorine-free high-performance elastomer with adapted antioxidants
AGC aims to achieve a continuous and stable supply of fluoropolymers, which is indispensable for the realization of a carbon-neutral and digital society
Most of the Capex this year is towards expanding our new fluoropolymers portfolio and for the next year it will be more towards the EV segment, both battery chemicals, and fluoropolymers used in the EV space
New fluoropolymers exports market has just opened up for GFL.
GFL is planning to put up a blending facility for R-410a in the Middle East immediately. The company also plans to expand its AHF capacity from 120tpd to 220tpd, which will help supply key starting raw materials for fluoropolymer, ref-gas and battery chemicals.
This decision is the next step in its commitment to voluntarily phase out the use of fluorosurfactants globally
The company has posted net profit of Rs. 820.50 crore for the 6 months period ended September 30, 2025
Speakers for the Session are: Venkata Prasad K., Unit Head, Deepak Nitrite; Abhilash Pasham, Associate General Manager - Central Engineering & Projects, Dr. Reddy's Laboratories; C. V. Rajulu, Consultant, Industry; and Jyoti Shankar Jha, Senior Lead Scientist, Alleima India. The moderator for the Session is Pravin Prashant, Executive Editor, Indian Pharma Post
Subscribe to our newsletter & stay updated.